SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-04-003326
Filing Date
2004-03-15
Accepted
2004-03-15 16:42:56
Documents
11
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 CAMBREX CORPORATION y94703e10vk.txt 10-K 400565
3 REVISED SCHEDULE OF PARTIES y94703exv10w21.txt EX-10.21 1775
4 2001 PERFORMANCE STOCK OPTION PLAN y94703exv10w33.txt EX-10.33 29480
5 2003 PERFORMANCE STOCK OPTION PLAN y94703exv10w34.txt EX-10.34 30451
6 SUBSIDIARIES OF REGISTRANT y94703exv21.txt EX-21 1675
7 CONSENT OF PRICEWATERHOUSECOOPERS LLP y94703exv23.txt EX-23 654
8 POWERS OF ATTORNEY y94703exv24.txt EX-24 3957
9 CEO CERTIFICATION y94703exv31w1.txt EX-31.1 3775
10 CFO CERTIFICATION y94703exv31w2.txt EX-31.2 3765
11 CEO CERTIFICATION y94703exv32w1.txt EX-32.1 1457
12 CFO CERTIFICATION y94703exv32w2.txt EX-32.2 1442
  Complete submission text file 0000950123-04-003326.txt   481771
Mailing Address ONE MEADOWLANDS PLAZA E. RUTHERFORD NJ 07073
Business Address ONE MEADOWLANDS PLZ E RUTHERFORD NJ 07073 2018043000
CAMBREX CORP (Filer) CIK: 0000820081 (see all company filings)

IRS No.: 222476135 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-10638 | Film No.: 04670055
SIC: 2834 Pharmaceutical Preparations